Literature DB >> 29033515

CHA2DS2-VASc Score: A Simple But Not Appropriate Risk Score for Predicting Mortality Risk in Patients with Heart Failure.

Chun-Li Wang1,2.   

Abstract

Entities:  

Year:  2017        PMID： 29033515      PMCID： PMC5534424          DOI： 10.6515/acs20170523a

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  17 in total

1.  Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.

Authors:  Line Melgaard; Anders Gorst-Rasmussen; Deidre A Lane; Lars Hvilsted Rasmussen; Torben Bjerregaard Larsen; Gregory Y H Lip
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

2.  Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.

Authors:  Stuart J Pocock; Cono A Ariti; John J V McMurray; Aldo Maggioni; Lars Køber; Iain B Squire; Karl Swedberg; Joanna Dobson; Katrina K Poppe; Gillian A Whalley; Rob N Doughty
Journal:  Eur Heart J       Date:  2012-10-24       Impact factor: 29.983

3.  Natriuretic peptides as a prognostic marker and therapeutic target in heart failure.

Authors:  G A Wright; A D Struthers
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

4.  Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score.

Authors:  Michele Senni; Piervirgilio Parrella; Renata De Maria; Ciro Cottini; Michael Böhm; Piotr Ponikowski; Gerasimos Filippatos; Christophe Tribouilloy; Andrea Di Lenarda; Fabrizio Oliva; Giovanni Pulignano; Mariantonietta Cicoira; Savina Nodari; Maurizio Porcu; Gianni Cioffi; Domenico Gabrielli; Oberdan Parodi; Paolo Ferrazzi; Antonello Gavazzi
Journal:  Int J Cardiol       Date:  2011-11-29       Impact factor: 4.164

5.  CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.

Authors:  Gokturk Ipek; Tolga Onuk; Mehmet B Karatas; Baris Gungor; Altug Osken; Muhammed Keskin; Ahmet Oz; Ozan Tanik; Mert Ilker Hayiroglu; Hale Yilmaz Yaka; Recep Ozturk; Osman Bolca
Journal:  Angiology       Date:  2015-12-17       Impact factor: 3.619

6.  Elevated level of high-sensitivity C-reactive protein is important in determining prognosis in chronic heart failure.

Authors:  Güliz Kozdağ; Gökhan Ertaş; Teoman Kiliç; Eser Acar; Ayşen Ağir; Tayfun Sahin; Metin Cetin; Ulaş Bildirici; Dilek Ural
Journal:  Med Sci Monit       Date:  2010-03

7.  Global Longitudinal Strain Is a Superior Predictor of All-Cause Mortality in Heart Failure With Reduced Ejection Fraction.

Authors:  Morten Sengeløv; Peter Godsk Jørgensen; Jan Skov Jensen; Niels Eske Bruun; Flemming Javier Olsen; Thomas Fritz-Hansen; Kotaro Nochioka; Tor Biering-Sørensen
Journal:  JACC Cardiovasc Imaging       Date:  2015-11-11

8.  Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.

Authors:  Simona Barlera; Luigi Tavazzi; Maria Grazia Franzosi; Roberto Marchioli; Elena Raimondi; Serge Masson; Renato Urso; Donata Lucci; Gian Luigi Nicolosi; Aldo P Maggioni; Gianni Tognoni
Journal:  Circ Heart Fail       Date:  2012-11-14       Impact factor: 8.790

9.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

10.  The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure.

Authors:  Jeptha P Curtis; Seth I Sokol; Yongfei Wang; Saif S Rathore; Dennis T Ko; Farid Jadbabaie; Edward L Portnay; Stephen J Marshalko; Martha J Radford; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.